U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264543) titled 'Early Methylene Blue in the Microhemodynamics of Septic Shock Patients' on Nov. 21.
Brief Summary: The aim of the study is to evaluate the viability and feasibility of the study protocol in order to conduct a larger clinical trial, assessing the microhemodynamic response to methylene blue infusion, through the capillary refill time measure, in septic shock patients.
Study Start Date: Dec. 03
Study Type: INTERVENTIONAL
Condition:
Septic Shock
Hypoperfusion
Intervention:
DRUG: Methylene blue infusion
Methylene blue at a dose of 100mg (diluted in 100ml of 5% dextrose solution) in continuous infusion for 06 hours per day, for 03 d...